immunocompromised patients – Page 2

Endogenous Endophthalmitis: An underestimated serious complication in patients with disseminated fusariosis

mycolabadmin

An 18-year-old leukemia patient developed a serious fungal eye infection from Fusarium during cancer treatment. The infection spread through the bloodstream to both eyes, causing serious inflammation and vision loss. Doctors treated it with multiple antifungal medications injected directly into the eyes along with systemic medication, which controlled the infection but unfortunately the patient’s vision was significantly affected. This case highlights how rare but serious eye infections can occur in cancer patients with weakened immune systems.

Differential composition of the pulmonary microbiome in HIV-positive versus HIV-negative patients with Pneumocystis jirovecii

mycolabadmin

This study compared lung infections in HIV-positive and HIV-negative patients who both had Pneumocystis jirovecii. Researchers found that HIV-positive patients had more diverse microorganisms in their lungs, particularly viruses, yet generally did better. HIV-negative patients had fewer types of microorganisms but worse outcomes. The findings suggest that the way a person’s immune system is weakened matters more than just having many germs present.

Detection and diagnostic process of liver abscess secondary to chemotherapy by mucor indicus in a patient with acute leukemic disease: case report

mycolabadmin

A 60-year-old man with acute leukemia developed a serious fungal infection in his liver caused by Mucor indicus after receiving chemotherapy that weakened his immune system. Doctors identified the infection through tissue samples and genetic testing, then treated him successfully with antifungal medications amphotericin B and posaconazole. This case highlights the importance of early detection and proper diagnosis of rare fungal infections in cancer patients undergoing chemotherapy.

Simultaneous infection with Fusarium proliferatum and Prototheca wickerhamii localized at different body sites

mycolabadmin

An 81-year-old woman taking long-term steroid medication developed two different fungal skin infections on her hands simultaneously – one on the right hand from a moldy wooden frame and one on the left hand possibly from sewage exposure. Doctors identified both fungi through microscopy and genetic testing. She was successfully treated with an antifungal medication called voriconazole for four weeks and recovered completely.

Catastrophic Cerebral Infarctions in a Pediatric Patient with Acute Lymphoblastic Leukemia Due to Mucorales Infection

mycolabadmin

An 11-year-old girl with leukemia undergoing chemotherapy developed a severe fungal infection called mucormycosis caused by Lichtheimia ramosa. The infection spread rapidly from her sinuses to her eyes and brain, causing multiple blood clots in brain arteries and a massive stroke within just five days. Despite emergency surgery to remove the clots, the infection had progressed too far and the patient sadly did not survive, highlighting how dangerous this fungal infection can be in children with weakened immune systems.

Phaeoacremonium tuscanicum and Phaeoacremonium indicum sp. nov. associated with subcutaneous phaeohyphomycosis

mycolabadmin

Researchers identified and described two rare fungal infections caused by Phaeoacremonium species in human patients. One case involved a previously unknown fungal species in humans called Phaeoacremonium indicum, discovered in an Indian transplant patient with a knee infection. Both cases were successfully treated with surgery, with one patient also receiving antifungal medication, demonstrating effective treatment approaches for these unusual infections.

Clinical aspects and recent advances in fungal diseases impacting human health

mycolabadmin

Fungal infections affect over a billion people worldwide and are becoming harder to treat due to growing resistance to antifungal medications. The review discusses major challenges in detecting and treating these infections, including difficulty in diagnosis and limited awareness among healthcare providers. New antifungal drugs are being developed and approved to address these challenges, but a comprehensive approach involving better awareness, improved testing, and responsible medication use is needed.

Tailoring mRNA lipid nanoparticles for antifungal vaccines

mycolabadmin

Researchers are exploring mRNA vaccines, similar to those used for COVID-19, as a new approach to prevent fungal infections. These vaccines use fatty particles called lipid nanoparticles to deliver instructions to cells on how to make fungal proteins, triggering an immune response. The review discusses how to optimize these vaccines, what challenges need to be overcome, and why they might be especially useful for people with weakened immune systems who are most vulnerable to serious fungal infections.

Musculoskeletal Manifestations of Disseminated Fungal Infections

mycolabadmin

Fungal infections can spread to bones and joints, causing serious complications especially in people with weakened immune systems. These infections are tricky to diagnose because their symptoms are similar to bacterial infections or other diseases. Treatment typically involves antifungal medications and sometimes surgery to remove infected tissue. Early detection and aggressive treatment are crucial for better patient outcomes.

Data analysis of patients with positive mould or dimorphic fungal cultures from sterile sites

mycolabadmin

This study examined 48 patients with serious mould and fungal infections at a South African hospital between 2014-2017. Most infections occurred in people with weak immune systems, especially those with HIV. The most common fungal type was Aspergillus. Even with appropriate antifungal medicines, one-quarter of patients died, highlighting how serious these infections can be.

Research Topic: immunocompromised patients